Immunovant (IMVT) Other Non Operating Income (2018 - 2026)
Immunovant's Other Non Operating Income was $4,000 in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 99.7% from $1.19 million a year earlier and down 99.5% from the prior quarter.
Powered by 
Analysis
Immunovant (IMVT) Other Non Operating Income (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Immunovant's Other Non Operating Income was $998,000 through Jun 30, 2026, down 38.7% year-over-year; for FY2026 (ended Mar 31, 2026), it was $2.18 million, up 363.1% from FY2025.
- Other Non Operating Income shows a five-year compound annual growth rate of 46.1% (FY2021 to FY2026).
- In earlier fiscal years, Other Non Operating Income was $471,000 in FY2025, -$1.01 million in FY2024, -$253,000 in FY2023 and -$781,000 in FY2022.
- Quarterly Other Non Operating Income has moved between -$2.59 million (fiscal Q4 2024) and $1.19 million (fiscal Q1 2026) over five years.
- The best year-over-year quarter for Other Non Operating Income over five years was fiscal Q4 2023 (growth of 709.1%); the worst was fiscal Q1 2027 (a decline of 99.7%).
- Per Business Quant data, IMVT's Other Non Operating Income in the three fiscal quarters before Q1 2027 was $798,000 (Q4 2026), -$54,000 (Q3 2026) and $250,000 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Immunovant | 6.94 Bn | 6.94 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4,000.00 |
| Mar 31, 2026 | 798,000.00 |
| Dec 31, 2025 | -54,000.00 |
| Sep 30, 2025 | 250,000.00 |
| Jun 30, 2025 | 1.19 Mn |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | -1.26 Mn |
| Sep 30, 2024 | 629,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Mar 31, 2024 | -2.59 Mn |
| Dec 31, 2023 | 1.09 Mn |
| Sep 30, 2023 | 20,000.00 |
| Jun 30, 2023 | 464,000.00 |
| Mar 31, 2023 | 356,000.00 |
| Dec 31, 2022 | -1.76 Mn |
| Sep 30, 2022 | 793,000.00 |
| Jun 30, 2022 | 354,000.00 |
| Mar 31, 2022 | 44,000.00 |
| Dec 31, 2021 | -114,000.00 |
| Sep 30, 2021 | -84,000.00 |
API Access
Immunovant Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();